Literature DB >> 32123901

Operative Treatment of a Superior Cerebellar Artery Perforator Dissecting Aneurysm.

Jonathan J Lee1, Meng Huang1, Jaime Guerrero1, Virendra R Desai1, Amanda Jenson1, Ryan Austerman1, Orlando Diaz1, Gavin W Britz1.   

Abstract

BACKGROUND AND IMPORTANCE: Superior cerebellar artery (SCA) perforator aneurysms are extremely rare, with only one other case published in the literature. There is no conclusive management strategy for these aneurysms, although endovascular treatment, open surgical treatment with clipping, and antifibrinolytic administration with spontaneous thrombosis have all been discussed. CLINICAL
PRESENTATION: A 61-yr-old male presented with intraventricular hemorrhage (IVH) primarily in the posterior fossa. He was found to have a dissecting left SCA perforator aneurysm lying on the floor of the fourth ventricle. The aneurysm was not amenable to endovascular treatment, and antifibrinolytic therapy failed to spontaneously thrombose the aneurysm. We performed a suboccipital craniotomy and used a supracerebellar transvermian approach to resect the aneurysm. There was total obliteration of the aneurysm on postoperative cerebral angiogram.
CONCLUSION: SCA perforator aneurysms represent an extremely uncommon subset of intracranial aneurysms. The best therapeutic strategy has yet to be definitively proven. When pursuing surgical treatment, the supracerebellar transvermian navigated approach can be a useful and safe option, as described and illustrated in this video.
Copyright © 2020 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Aneurysm; Perforator; Superior cerebellar artery; Supracerebellar; Transvermian

Mesh:

Year:  2020        PMID: 32123901     DOI: 10.1093/ons/opz407

Source DB:  PubMed          Journal:  Oper Neurosurg (Hagerstown)        ISSN: 2332-4252            Impact factor:   2.703


  1 in total

1.  Woven Endobridge device for treatment of dissection-related PICA aneurysm.

Authors:  Nicolas K Khattar; Andrew C White; Aurora S Cruz; Shawn W Adams; Kimberly S Meyer; Haring Jw Nauta; Dale Ding; Robert F James
Journal:  Interv Neuroradiol       Date:  2020-10-18       Impact factor: 1.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.